Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 36.79% is 44% below its 5-year average of 65.89%, near the low end of its 5-year range (33.67%–143.98%).
As of the fiscal period ended Tuesday, June 30, 2026. 5.54% below its 12-month average of 38.95%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 36.79%.
DEBT TO ASSETS RATIO
36.79%
DEBT TO ASSETS RATIO AVG TTM
38.95%
DEBT TO ASSETS RATIO AVG 3Y
66.02%
DEBT TO ASSETS RATIO AVG 5Y
65.89%
DEBT TO ASSETS RATIO AVG 10Y
69.81%
DEBT TO ASSETS RATIO AVG 15Y
69.75%
DEBT TO ASSETS RATIO AVG 20Y
59.30%
CURRENT VS TTM AVG
-5.54%
CURRENT VS 3Y AVG
-44.27%
CURRENT VS 5Y AVG
-44.16%
CURRENT VS 10Y AVG
-47.30%
CURRENT VS 15Y AVG
-47.25%
CURRENT VS 20Y AVG
-37.95%
SECTOR MEDIAN · HEALTHCARE
0.10%
median of 671 covered companies
CURRENT VS SECTOR MEDIAN
+36692.02%
vs the sector median at left
Caris Life Sciences, Inc.
Market Cap
$8.14B
Debt to Assets Ratio
36.79%
TTM Avg
38.95%
3Y Avg
66.02%
5Y Avg
65.89%
Market Cap
$7.71B
Debt to Assets Ratio
0.66%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.67B
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.76B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.38B
Debt to Assets Ratio
0.81%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Caris Life Sciences, Inc. (CAI) | $8.14B | 36.79% | 38.95% | 66.02% | 65.89% |
| Oscar Health, Inc. (OSCR)vs › | $8.45B | 0.04% | N/A | N/A | N/A |
| Cytokinetics, Incorporated (CYTK)vs › | $7.71B | 0.66% | N/A | N/A | N/A |
| Kymera Therapeutics, Inc. (KYMR)vs › | $8.67B | 0.05% | N/A | N/A | N/A |
| HealthEquity, Inc. (HQY)vs › | $7.58B | 0.30% | N/A | N/A | N/A |
| Hinge Health, Inc. (HNGE)vs › | $7.53B | 0.01% | N/A | N/A | N/A |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.76B | 0.41% | N/A | N/A | N/A |
| Ionis Pharmaceuticals, Inc. (IONS)vs › | $7.38B | 0.81% | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $8.98B | 0.32% | N/A | N/A | N/A |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.04B | 0.29% | N/A | N/A | N/A |
Debt/Assets
36.8%
Debt/Equity
0.76
Current Ratio
5.53
Interest Coverage
0.8x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 36.79% |
| 2026-03-31 | 37.08% |
| 2025-12-31 | 33.67% |
| 2025-09-30 | 43.34% |
| 2025-06-30 | 43.87% |
| 2025-03-31 | 143.98% |
| 2024-12-31 | 123.43% |
| 2021-09-30 | 69.18% |
| 2021-06-30 | 61.69% |
| 2021-03-31 | 68.25% |
| 2020-12-31 | 66.82% |
| 2020-09-30 | 71.95% |
| 2020-06-30 | 72.09% |
| 2020-03-31 | 73.13% |
| 2019-12-31 | 72.31% |
| 2019-09-30 | 72.16% |
| 2019-06-30 | 71.66% |
| 2019-03-31 | 71.40% |
| 2018-12-31 | 71.67% |
| 2018-09-30 | 65.75% |
| 2018-06-30 | 67.60% |
| 2018-03-31 | 67.95% |
| 2017-12-31 | 70.06% |
| 2017-09-30 | 67.22% |
| 2017-06-30 | 69.96% |
| 2017-03-31 | 70.74% |
| 2016-12-31 | 71.79% |
| 2016-09-30 | 71.18% |
| 2016-06-30 | 71.24% |
| 2016-03-31 | 71.59% |
| 2015-12-31 | 72.07% |
| 2015-09-30 | 70.98% |
| 2015-06-30 | 71.02% |
| 2015-03-31 | 68.99% |
| 2014-12-31 | 70.33% |
| 2014-09-30 | 69.15% |
| 2014-06-30 | 69.66% |
| 2014-03-31 | 68.68% |
| 2013-12-31 | 67.72% |
| 2013-09-30 | 70.54% |
| 2013-06-30 | 70.40% |
| 2013-03-31 | 67.78% |
| 2012-12-31 | 68.61% |
| 2012-09-30 | 67.48% |
| 2012-06-30 | 54.71% |
| 2012-03-31 | 55.00% |
| 2011-12-31 | 58.06% |
| 2011-09-30 | 59.35% |
| 2011-06-30 | 54.39% |
| 2011-03-31 | 43.36% |
| 2010-12-31 | 40.76% |
| 2010-09-30 | 37.97% |
| 2010-06-30 | 39.80% |
| 2010-03-31 | 44.47% |
| 2009-12-31 | 44.98% |
| 2009-09-30 | 47.20% |
| 2009-06-30 | 47.25% |
| 2009-03-31 | 49.79% |
| 2008-12-31 | 51.55% |
| 2008-09-30 | 46.95% |
| 2008-06-30 | 43.65% |
| 2008-03-31 | 39.87% |
| 2007-12-31 | 41.11% |
| 2007-09-30 | 37.30% |
| 2007-06-30 | 31.76% |
| 2007-03-31 | 55.08% |
| 2006-12-31 | 54.34% |
